Charles Ornstein

Charles Ornstein appears in the following:

Opioid-Makers Cut Back On Marketing Payments To Doctors

Thursday, June 28, 2018

ProPublica found that drugmakers spent less to market opioids to doctors in 2016 than in prior years. Studies have shown that payments to doctors are linked to more prescriptions for the drugs.

Comment

'Extreme' Opioid Use And Doctor Shopping Still Plague Medicare

Thursday, July 13, 2017

One-third of all Medicare recipients were prescribed opioids last year, the HHS inspector general says, with more than half a million getting high doses for at least three months.

Comment

States Move To Tighten Medicaid Enrollment, Even Without A New Health Law

Thursday, July 06, 2017

Some states are seeking to make major changes in their Medicaid programs that would end coverage for millions of people, even if the Affordable Care Act isn't repealed.

Comment

Doctors Prescribe More Generics When Drug Reps Are Kept At Bay

Tuesday, May 02, 2017

Doctors were more likely to choose generic drugs over pricier brand names when teaching hospitals limited access by pharmaceutical sales representatives, a study finds.

Comment

Secret Data On Hospital Inspections May Soon Become Public

Tuesday, April 18, 2017

The federal government wants to require that private accreditors release reports of problems they find during hospital inspections. Right now, the reports are kept confidential.

Comment

How A Simple Fix For Medicare Prescribing Problems Got Complicated

Friday, February 10, 2017

In 2014, the government said health providers would have to register with Medicare in order to prescribe drugs to beneficiaries. Delays have pushed back the requirement until 2019.

Comment

Drug Distributors Penalized For Turning Blind Eye In Opioid Epidemic

Friday, January 27, 2017

The wholesalers that move medicines between drug companies and pharmacies have been fined for failing to call out suspicious transactions involving opioids.

Comment

From Twitter To Treatment Guidelines, Industry Influence Permeates Medicine

Tuesday, January 17, 2017

Several new studies document widespread conflicts of interest in medicine. The way we think about disease "is being subtly distorted" by financial ties, the authors of an accompanying editorial write.

Comment

A Growing Group Of Doctors Are Big-Money Prescribers In Medicare

Thursday, November 17, 2016

In 2011, just 41 health care providers prescribed more than $5 million each in medicines under Medicare Part D. In 2015, that number was 514. The rise of expensive hepatitis C drugs is a factor.

Comment

Federal Officials Seek To Stop Social Media Abuse Of Nursing Home Residents

Monday, August 08, 2016

After ProPublica identified dozens of cases of dehumanizing photos posted on social media sites, the Centers for Medicare and Medicaid Services unveiled a plan to increase oversight.

Comment

Social Media Abuse Of Nursing Home Residents Often Goes Unchecked

Thursday, July 14, 2016

Iowa health officials recently discovered it wasn't against state law for a nursing home worker to share a photo on Snapchat of a resident covered in feces. They are trying to change that.

Comment

Doctors At Southern Hospitals Take The Most Payments From Drug, Device Companies

Wednesday, June 29, 2016

A hospital's location and whether it is for-profit make a big difference in the share of its doctors taking industry payments like meals, travel and speaking fees. Check out the ProPublica analysis.

Comment

Even A Small Meal For A Doctor Can Tip The Balance For A Brand-Name Drug

Tuesday, June 21, 2016

Researchers say the time doctors spend with drug company representatives when they are dropping off meals is probably more important than the food in influencing prescription choices.

Comment

What Feds' Push To Share Health Data Means For Patients

Monday, May 09, 2016

ProPublica's Charles Ornstein spoke with Niall Brennan about making health data from the Centers for Medicare and Medicaid Services more widely available outside the government.

Comment

Drug-Company Payments Mirror Doctors' Brand-Name Prescribing

Thursday, March 17, 2016

An analysis of Medicare data shows that the more money a doctor gets from pharmaceutical companies, the more likely he or she is to prescribe brand-name medications. And that influences cost.

Comment

Supreme Court Strikes At States' Efforts On Health Care Transparency

Wednesday, March 02, 2016

The U.S. Supreme Court dealt a blow Tuesday to nascent efforts to track the quality and cost of health care, ruling that a 1974 law precludes states from requiring that every health care claim involving their residents be submitted to a massive database.

The arguments were arcane, but the ...

Comment

Privacy Violations Rising At Veterans Affairs Medical Facilities

Wednesday, December 30, 2015

When Anthony McCann opened a thick manila envelope from the Department of Veterans Affairs last year, he expected to find his own medical records inside.

Instead, he found over 250 pages of deeply revealing personal information on another veteran's mental health.

"It had everything about him, and I could ...

Comment

Repeat Violators Of Health Privacy Laws Often Go Unpunished

Tuesday, December 29, 2015

Regulators have logged dozens, even hundreds of complaints against some health providers for violating federal patient privacy law. Warnings are doled out privately, and sanctions are rarely imposed.

Comment

Celebrities' Medical Records Tempt Hospital Workers To Snoop

Thursday, December 10, 2015

Improper access to the medical information of celebrities and people in the news has been a bane of health systems around the country for years. The proliferation of electronic medical records systems has made it easier to track and punish those who peek in records for no legitimate reason.

Below ...

Comment

Small Violations Of Medical Privacy Can Hurt Patients And Erode Trust

Thursday, December 10, 2015

Breaches that expose the health details of just a patient or two are proliferating nationwide. Regulators focus on larger privacy breaches and rarely take action on small ones, despite their harm.

Comment